摘要目的:探讨吉西他滨联合放疗治疗老年中晚期宫颈癌患者的临床效果。方法:选取2016年12月至2018年8月本院收治老年中晚期宫颈癌患者84例，按照随机、对照原则将其分为单纯放疗组和联合放疗组，其中联合放疗组在单纯放疗的基础上联合吉西他滨，对两组患者近期疗效、远期疗效和不良反应发生情况进行评估分析。结果:两组患者经过治疗其肿瘤均得到有效控制，其中单纯放疗组患者总治疗有效率为67.6%，低于联合放疗组(87.2%)( χ2＝4.756， P＝0.029)；联合放疗组患者生存率(89.4%和59.5%， χ2＝10.204， P＝0.001)、无局部复发率(83.0%和54.1%， χ2＝8.286， P＝0.004)、无远处转移生存率(83.0%和56.8%， χ2＝6.975， P＝0.008)均高于单纯放疗组；联合放疗组患者白细胞减少发生率高于单纯放疗组(38.3%和13.5%， χ2＝8.396， P＝0.011)。 结论:采用放疗联合吉西他滨治疗老年中晚期宫颈癌，可有效增强对患者癌变组织的控制效果，提高患者远期生存率，降低肿瘤局部复发风险。

abstractsObjective:To explore the clinical efficacy of Gemcitabine in combination with radiotherapy for elderly patients with cervical cancer .Methods:From December 2016 to August 2018, 84 elderly patients with advanced cervical cancer receiving treatment in our hospital were enrolled.As a randomized controlled study, patients were divided into the radiotherapy-alone group and the combined therapy group.Patients in the combined therapy group was given radiotherapy and Gemcitabine.The short- and long-term efficacy, and the rate of adverse reactions were evaluated for the two groups.Results:Tumors in both groups were effectively controlled after treatment.The overall rate of effectiveness in the radiotherapy-alone group was significantly lower than that in the combined therapy group(67.6% vs.87.2%, χ2=4.756, P=0.029). The combined therapy group was associated with a significantly higher survival rate(89.4% vs.59.5%, χ2=10.204, P=0.001), a local recurrence-free rate(83.0% vs.54.1%, χ2=8.286, P=0.004), and a distant metastasis-free survival rate(83.0% vs.56.8%, χ2=6.975, P=0.008), compared with the radiotherapy-alone group.Additionally, the incidence of leukopenia was higher in the combined therapy group than in the radiotherapy-alone group(38.3% vs.13.5%, χ2=8.396, P=0.011). Conclusion:The combination of radiotherapy with Gemcitabine for the treatment of advanced cervical cancer in elderly patients can effectively enhance control on cancerous tissues, improve the long-term survival rate, and reduce the risk of local recurrence.